Wasler A, Tscheliessnigg K H
Klinischen Abteilung für Transplantationschirurgie, Universitätsklinik für Chirurgie, Graz.
Wien Med Wochenschr. 1998;148(5):137-42.
Heart transplantation is an established therapy for end-stage cardiac disease. The number of organ donors is limited, and the mortality on the waiting list is increasing. To give these patients a chance to survive their waiting time, chronic mechanical circulatory support, especially left ventricular assist devices have been clinically established. The results with this therapy are encouraging. Because of these results trials using these devices as an alternative for cardiac transplantation are initiated. Due to the further development and miniaturization of such devices this indication will become more important. The most interesting patients are the one, in which devices could be explanted after chronic support, because their myocard has recovered. If we can find a way to identify such patients a new form of therapy for end-stage heart disease could be established.
心脏移植是终末期心脏病的一种既定治疗方法。器官捐献者数量有限,等待名单上的死亡率正在上升。为了让这些患者有机会在等待期间存活下来,慢性机械循环支持,尤其是左心室辅助装置已在临床上得到确立。这种治疗方法的效果令人鼓舞。基于这些结果,已启动将这些装置用作心脏移植替代方案的试验。由于此类装置的进一步发展和小型化,这一适应症将变得更加重要。最令人感兴趣的患者是那些在接受长期支持后可以移除装置的患者,因为他们的心肌已经恢复。如果我们能够找到一种方法来识别这类患者,那么终末期心脏病的一种新的治疗形式就可以确立。